Name: Jeremy Skillington of Poolbeg Pharma discusses their Nasdaq partnership for development
Uploaded: 2023-10-17T06:59:55.081325+00:00
Duration: 368 s
Channel: Vox Markets
Description: Jeremy Skillington CEO of Poolbeg Pharma #POLB discusses their partnership with Nasdaq-Listed Biopharma company for the development of an optimised oral drug to treat a metabolic condition. Under the agreement, the Company will receive funding to work with its new partner to produce a prototype drug utilising Poolbeg's licensed oral delivery technology.

Vox Markets

Jeremy Skillington CEO of Poolbeg Pharma #POLB discusses their partnership with Nasdaq-Listed Biopharma company for the development of an optimised oral drug to treat a metabolic condition. Under the agreement, the Company will receive funding to work with its new partner to produce a prototype drug utilising Poolbeg's licensed oral delivery technology.

<p>Jeremy Skillington CEO of Poolbeg Pharma #POLB discusses their partnership with Nasdaq-Listed Biopharma company for the development of an optimised oral drug to treat a metabolic condition. Under the agreement, the Company will receive funding to work with its new partner to produce a prototype drug utilising Poolbeg's licensed oral delivery technology.</p>

https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/006/466/006466/video_Isi5qsL.mp4